Letter to the Editor Analysis of the penA Gene of Pseudomonas cepacia 249
In the April issue ofAntimicrobial Agents and Chemotherapy (6) , Proenca et al. described the cloning and sequencing of a 1.1-kb DNA fragment reportedly containing the penA gene encoding the chromosomal 1-lactamase of Pseudomonas cepacia 249 and deduced the primary structure of an unprocessed protein of 313 residues which was declared to belong to the AmpC family of ,B-lactamases, i.e., to structural class C (2). However, two important sequence elements which characterize these enzymes Author's Reply Dr. Joris et al. provide a detailed computer analysis of the sequence of the penA ,-lactamase that we had previously described (1). As we reported, the active site serine was much closer to the C terminus than in any other reported P-lactamases, and Dr. Joris' homology searches for the predicted protein revealed strong similarity with an E. coli isoleucyltRNA synthetase, particularly when several frameshifts are allowed. Obviously, the DNA sequence alone does not support the contention that this is a 1-lactamase. Moreover, as demonstrated in the initial description of this enzyme, the penA ,-lactamase differs significantly from the chromosomal ,-lactamases of other gram-negative organisms in its substrate profile and kinetics, although as demonstrated by Southern hybridization, it clearly is derived from P. cepacia 249 (2). As P. cepacia has a well-described facility for acquiring foreign genes from other organisms, we hypothesized that this 1-lactamase was originally derived from members of the family Enterobacteriaceae.
Support for this hypothesis was provided by the series of genetic studies demonstrating that penA expression could be regulated by the E. coli ampD locus and that a putative P. cepacia AmpR homolog could positively regulate Enterobacter cloacae ampC. Moreover, the putative P. cepacia ampR was found to have homology to the E. cloacae ampR by Southern hybridization, and gel mobility shift assays further confirmed the ability of both the putative P. cepacia AmpR and the E. cloacae AmpR to bind to the DNA immediately upstream of the penA coding sequence.
Thus, the combination of these genetic studies, evidence of the appropriate protein-DNA interactions, and key sequence elements, including the presence of an active site serine and five separate regions of >69% DNA identity with E. coli and/or E. cloacae ampC DNA, supports our contention that P. cepacia acquired an ampC-type ,B-lactamase or at least a portion of the operon from the Enterobacteriaceae.
Furthermore, there is a precedent for the association of 1-lactamase activity with genes found to have other biological functions. The amino acid sequence deduced from the nucleotide sequence of the region immediately upstream of the cytochrome c oxidase subunit II from Paracoccus denitrificans was found to have a very high degree of homology to gramnegative f-lactamases and codon usage more typical of E. coli (3), although P. denitrificans is not known to contain a f-lactamase. With Streptomyces cacaoi, nucleotide sequence analysis of the r-lactamase coding region revealed several open reading frames which contain sequences typical of DNAbinding activator proteins, and a minimal active site serine region but little homology to other well-characterized enzyoies with j-lactamase activity (4). Thus, it is not unprecedented to find portions of genetic elements associated with P-lactamase activity which do not conform to the genuine enzymes which have been so well characterized by Dr. Joris and his collaborators. The ability of P. cepacia to acquire and express genes from diverse sources undoubtedly contributes to its wide metabolic capabilities and success as an opportunistic pathogen.
